Details for New Drug Application (NDA): 212160
✉ Email this page to a colleague
The generic ingredient in DEXTROAMPHETAMINE SULFATE is dextroamphetamine sulfate. There are eighteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.
Summary for 212160
Tradename: | DEXTROAMPHETAMINE SULFATE |
Applicant: | Winder Labs Llc |
Ingredient: | dextroamphetamine sulfate |
Patents: | 0 |
Pharmacology for NDA: 212160
Physiological Effect | Central Nervous System Stimulation |
Medical Subject Heading (MeSH) Categories for 212160
Suppliers and Packaging for NDA: 212160
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | TABLET;ORAL | 212160 | ANDA | Winder Laboratories LLC | 75826-120 | 75826-120-10 | 100 TABLET in 1 BOTTLE, PLASTIC (75826-120-10) |
DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | TABLET;ORAL | 212160 | ANDA | Winder Laboratories LLC | 75826-120 | 75826-120-30 | 30 TABLET in 1 BOTTLE, PLASTIC (75826-120-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
Approval Date: | Jun 7, 2021 | TE: | AA | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Jun 7, 2021 | TE: | AA | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 7.5MG | ||||
Approval Date: | Jun 7, 2021 | TE: | AA | RLD: | No |
Complete Access Available with Subscription